Back to all journals
journal articles
LETTER TO THE EDITOR: DONANEMAB THERAPY IN ALZHEIMER’S DISEASE WITH MILD COGNITIVE IMPAIRMENT: CONVERGENT AMYLOID, TAU, AND PLASMA BIOMARKER NORMALIZATION WITH COGNITIVE IMPROVEMENT
Limoran Tang, Yun Xu, Hui Zhao
CITATION:
Limoran Tang ; Yun Xu ; Hui Zhao (): Letter to the Editor: Donanemab therapy in Alzheimer’s disease with mild cognitive impairment: Convergent amyloid, tau, and plasma biomarker normalization with cognitive improvement. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2026.100533